Prognostic Factors in Chondrosarcomas
Author Information
Author(s): S. Daugaard, Olaf Myhre-Jensen, Torben Schie DT, Anne G. Jurik, Johnny Keller, Henning T. Mouridsen, Bjarne Lund
Primary Institution: Rigshospitalet (University Hospital), Copenhagen and Aarhus University Hospital, Denmark
Hypothesis
What clinical and histopathological factors are important for prognosis in chondrosarcomas?
Conclusion
The adequacy of surgical treatment and the patient's age are important prognostic factors in chondrosarcomas.
Supporting Evidence
- Patients treated with curative intent had a median survival of 14.7 years.
- Only surgical margin, cellularity, and pleomorphism were significantly related to recurrence-free survival.
- Age, sex, and extra-compartmental growth were statistically significant for overall survival.
Takeaway
Doctors looked at 115 patients with a type of bone cancer called chondrosarcoma to find out what factors affect how long patients live after treatment. They found that how well the surgery went and the patient's age are really important.
Methodology
The study reviewed 115 cases of chondrosarcomas, excluding 11 patients who only had a biopsy, and analyzed various clinical and histopathological features for their prognostic value.
Potential Biases
The subjective nature of histopathological grading may introduce bias in determining prognostic factors.
Limitations
The study had a relatively small sample size and the grading of chondrosarcomas was found to be subjective with low inter-observer agreement.
Participant Demographics
The study included 115 patients with chondrosarcomas, with a range of ages from 4 to 83 years.
Statistical Information
P-Value
0.0002
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website